Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
about
Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial)
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@ast
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@en
type
label
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@ast
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@en
prefLabel
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@ast
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@en
P2093
P2860
P50
P356
P1433
P1476
Rationale and design of the or ...... is patients (HEMATOCRIT trial)
@en
P2093
Carolyn L van Eps
Diana Leary
Euan Noble
Fiona Brown
Joanna M Sturtevant
Katherine A Barraclough
Nicole M Isbel
Scott B Campbell
P2860
P2888
P356
10.1186/1471-2369-10-20
P577
2009-07-28T00:00:00Z
P5875
P6179
1018737729